Skip to search formSkip to main contentSkip to account menu

denileukin diftitox/dexamethasone

Known as: DAB389-IL2/DM 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Introduction:Denileukin diftitox, a chimeric protein, uses the cytocidal properties of diphtheria toxin to cells expressing… 
Highly Cited
2007
Highly Cited
2007
CD4+CD25+Foxp3+ regulatory T (Treg) cells have been implicated in the lack of effective antitumor immunity. Denileukin diftitox… 
2007
2007
Denileukin diftitox (DD; Ontak, Eisai, Woodcliff Lake, NJ) is an FDA-approved targeted therapy for cutaneous T-cell lymphoma… 
2006
2006
BACKGROUND Denileukin diftitox, a fusion protein consisting of peptide sequences for the enzymatically active and membrane… 
Highly Cited
2005
Highly Cited
2005
Elimination of regulatory T lymphocytes may provide a way to break self-tolerance and unleash the anti-tumor properties of…